The Latest on FA Research Research is the answer to one day making FA a treatable, manageable disease. On this page you’ll find the latest updates on FARF-funded research and activities. Each quarter, we’ll update this list with our newly...
Announcements
Enroll in study The National Cancer Institute (NCI) investigators Dr. Neelam Giri and Dr. Sharon Savage have teamed up with the Fanconi Anemia Research Fund (FARF) as part of the FA Cancer Consortium to develop a comprehensive program to screen...
Announcements
As we remember all of those we’ve lost, it’s important to acknowledge the shockwave that is grief, which can reverberate throughout the entire community during times of loss. Most in this community have witnessed the difficulties experienced by those with...
Announcements, Wellness, Grief
In 2022, the Fanconi Anemia Research Fund moved full steam ahead with research priorities. Notably, we invested over $3 million into new and ongoing research efforts, with a major focus on cancer through the development of the FA Cancer Consortium....
Announcements
New grants: Cancer Consortium The Fanconi Anemia Cancer Consortium (FACC) is a collaborative partnership between the FA community and a network of clinicians and physician scientists who have expertise in the diagnosis and management of FA cancers and FA cancer research....
Announcements
Why cancer? When the Fanconi Anemia Research Fund (FARF) was founded in 1989, Fanconi anemia (FA) was thought to be a childhood blood disease that led to leukemia. Thanks to years of donor-funded research, we now know that faulty DNA...
Announcements
